Abstract

The epidemiology of human leishmaniasis is most complex. Not only are there many species of the parasite in the tropics and subtropics, but each has different sand fly vectors and animal reservoirs and exhibits different behavior in humans. Where epidemiologic information is sufficient, one or more of four methods of control has been effectively used. These are spraying of houses with DDT to control domiciliated phlebotomines (southern Europe, India, Brazil), destruction of animal reservoirs (Brazil, USSR), mass treatment of patients (India, China), and vaccination (USSR, Israel). A drug replacing the pentavalent antimonials as the first-line treatment is a priority, since human infections resistant to currently available drugs occur in many countries and antimonials are difficult to give to outpatients. More research is needed on forest leishmaniasis in the tropical Americas; however, sand fly vectors and animal reservoirs seem inaccessible to control measures. If a vaccine can be developed, it might have great utility. There is an urgent need to map the distribution of predominant species infecting humans in Latin America, since treatment schedules differ for the various cutaneous infections.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.